$21.76
-0.65-2.90%
At close: -
$21.76
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
NewAmsterdam Pharma Co Insider Trading Activity | NASDAQ:NAMS | Benzinga
Track the latest NewAmsterdam Pharma Co insider trading activity. Stay informed on recent buys, sells, and market impact for NewAmsterdam Pharma Co stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are NewAmsterdam Pharma Co NV Insiders Doing?
At NewAmsterdam Pharma Co NV, recent insider activity has drawn attention. Over the last 30 days, insiders have report no sales in the last 30 days, meanwhile, insiders have reported buying a total of 5.14K shares for a total value of $109.72K.
Notable Recent Insider Buys and Sales
- On March 6, 2025, James N Topper, the company's - purchased 4.01K shares for $21.02 each.
- On March 28, 2025, James N Topper, the company's - purchased 1.14K shares for $22.49 each.
- On January 2, 2025, BV NAP ForGrowth, Forbion Capital Fund IV Cooperatief UA, Forbion IV Management BV, Forbion Growth Opportunities Fund I Cooperatief UA, Forbion Growth Management BV, the company's - sold 29.85K shares for $25.54 each.
Ownership Statistics for NewAmsterdam Pharma Co NV
Shares Outstanding
109.818M
Insider Shares Owned
347.433K
Insider Percentage Owned
0.32%
Institutional Shares Held
20.653M
Institutional Percentage Held
18.8%
| Mar 28, 2025 | James N Topper | — | 1.14K | $22.49 | $25.52K | BUY | 0.02% | 6.81M | Mar 26 | View |
| Mar 28, 2025 | Douglas F Kling | CHIEF OPERATING OFFICER | 0.00 | $0.00 | $0.00 | SELL-OPTIONS | 0.00% | 44.00K | Mar 26 | View |
| Mar 28, 2025 | Michael H Davidson | CHIEF EXECUTIVE OFFICER | 57.13K | $0.00 | $0.00 | SELL-OPTIONS | 17.14% | 390.44K | Mar 26 | View |
| Mar 19, 2025 | Douglas F Kling | CHIEF OPERATING OFFICER | 0.00 | $10.00 | $118.88K | SELL-OPTIONS | 0.00% | 44.00K | Mar 17 | View |
| Mar 06, 2025 | James N Topper | — | 4.00K | $21.02 | $84.20K | BUY | 0.06% | 6.81M | Mar 04 | View |
| Mar 05, 2025 | Louise Kooij | CHIEF ACCOUNTING OFFICER | 0.00 | $20.37 | -$3.06M | SELL-OPTIONS | 0.00% | 15.00K | Mar 04 | View |
| Feb 20, 2025 | Douglas F Kling | CHIEF OPERATING OFFICER | 0.00 | $0.00 | $0.00 | SELL-OPTIONS | 0.00% | 44.00K | Feb 18 - Feb 19 | View |
| Jan 31, 2025 | Douglas F Kling | CHIEF OPERATING OFFICER | 0.00 | $0.00 | $0.00 | SELL-OPTIONS | 0.00% | 44.00K | Jan 29 - Jan 30 | View |
| Jan 29, 2025 | Mayur Ian Somaiya | CHIEF FINANCIAL OFFICER | 0.00 | $9.26 | $573.04K | SELL-OPTIONS | 0.00% | 38.00K | Jan 27 - Jan 28 | View |
| Jan 29, 2025 | Douglas F Kling | CHIEF OPERATING OFFICER | 0.00 | $0.00 | $0.00 | SELL-OPTIONS | 0.00% | 44.00K | Jan 27 - Jan 28 | View |
| Jan 02, 2025 | BV NAP ForGrowthForbion Capital Fund IV Cooperatief UAForbion IV Management BVForbion Growth Opportunities Fund I Cooperatief UAForbion Growth Management BV | — | -29.85K | $25.54 | -$762.17K | SELL | -0.28% | 10.66M | Dec 30 | View |
| Dec 30, 2024 | BV NAP ForGrowthForbion Capital Fund IV Cooperatief UAForbion IV Management BVForbion Growth Opportunities Fund I Cooperatief UAForbion Growth Management BV | — | -74.91K | $25.98 | -$1.95M | SELL | -0.70% | 10.69M | Dec 26 - Dec 27 | View |
| Dec 26, 2024 | BV NAP ForGrowthForbion Capital Fund IV Cooperatief UAForbion IV Management BVForbion Growth Opportunities Fund I Cooperatief UAForbion Growth Management BV | — | -91.07K | $25.58 | -$2.33M | SELL | -0.84% | 10.76M | Dec 20 - Dec 24 | View |
| Dec 20, 2024 | BV NAP ForGrowthForbion Capital Fund IV Cooperatief UAForbion IV Management BVForbion Growth Opportunities Fund I Cooperatief UAForbion Growth Management BV | — | -157.23K | $25.86 | -$4.07M | SELL | -1.43% | 10.85M | Dec 18 - Dec 19 | View |
| Dec 18, 2024 | BV NAP ForGrowthForbion Capital Fund IV Cooperatief UAForbion IV Management BVForbion Growth Opportunities Fund I Cooperatief UAForbion Growth Management BV | — | -115.48K | $25.95 | -$3.00M | SELL | -1.04% | 11.01M | Dec 16 - Dec 17 | View |
| Dec 16, 2024 | BV NAP ForGrowthForbion Capital Fund IV Cooperatief UAForbion IV Management BVForbion Growth Opportunities Fund I Cooperatief UAForbion Growth Management BV | — | -191.76K | $25.34 | -$4.86M | SELL | -1.69% | 11.12M | Dec 12 - Dec 13 | View |
| Dec 12, 2024 | BV NAP ForGrowthForbion Capital Fund IV Cooperatief UAForbion IV Management BVForbion Growth Opportunities Fund I Cooperatief UAForbion Growth Management BV | — | -462.29K | $25.40 | -$11.74M | SELL | -3.92% | 11.32M | Dec 10 - Dec 11 | View |
| Nov 19, 2024 | BV NAP ForGrowthForbion Capital Fund IV Cooperatief UAForbion IV Management BVForbion Growth Opportunities Fund I Cooperatief UAForbion Growth Management BV | — | -41.80K | $25.07 | -$1.05M | SELL | -0.35% | 11.78M | Nov 15 - Nov 18 | View |
| Nov 15, 2024 | BV NAP ForGrowthForbion Capital Fund IV Cooperatief UAForbion IV Management BVForbion Growth Opportunities Fund I Cooperatief UAForbion Growth Management BV | — | -10.90K | $25.01 | -$272.51K | SELL | -0.09% | 11.82M | Nov 13 - Nov 14 | View |
| Oct 01, 2024 | Louise Kooij | CHIEF ACCOUNTING OFFICER | 0.00 | $15.72 | -$707.40K | SELL-OPTIONS | 0.00% | 0.00 | Sep 27 - Oct 01 | View |
| Sep 30, 2024 | Juliette Berangere Audet | CHIEF BUSINESS OFFICER | 1.10K | $15.70 | $17.33K | BUY | ∞ | 1.10K | Sep 26 | View |
| Aug 22, 2024 | Michael H Davidson | CHIEF EXECUTIVE OFFICER | 5.00K | $16.27 | $81.35K | BUY | 0.61% | 818.56K | Aug 20 | View |
| Jun 24, 2024 | Michael H Davidson | CHIEF EXECUTIVE OFFICER | 5.00K | $17.26 | $86.31K | BUY | 0.62% | 813.56K | Jun 20 | View |
| Mar 28, 2024 | James N Topper | — | 8.43K | $21.50 | $181.22K | BUY | 0.12% | 6.81M | Mar 26 | View |
| Mar 27, 2024 | Johannes Jacob Pieter Kastelein | CHIEF SCIENTIFIC OFFICER | 0.00 | $21.57 | -$4.35M | SELL-OPTIONS | 0.00% | 0.00 | Mar 26 | View |
| Feb 21, 2024 | Louis G Lange | — | 5.00K | $19.00 | $95.00K | BUY | 25.15% | 24.88K | Feb 13 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
NAMS Insider Trading News
No news found